title: Serial intracameral bevacizumab for uveitis-glaucoma-hyphema syndrome: a case report.
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alta.. Electronic address: rech@ualberta.ca.
authors.forename: Lia
authors.initials: L
authors.lastname: Rech
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alta.
authors.forename: Lisa
authors.initials: L
authors.lastname: Heckler
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alta.
authors.forename: Karim F
authors.initials: KF
authors.lastname: Damji
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D002387:Cataract Extraction; D002924:Ciliary Body / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D005901:Glaucoma / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006988:Hyphema / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D007429:Intraocular Pressure; D058449:Intravitreal Injections; D017075:Laser Coagulation; D019654:Lens Implantation, Intraocular / Q000009:adverse effects; D008875:Middle Aged; D013577:Syndrome; D014605:Uveitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab